Glenn Irwin agrees a two-year deal with the PBM Ducati team to compete in the 2025 and 2026 British Superbike championships.

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

“We have the leading PBM, the best-run pharmacy in this country, a storied franchise through Aetna, and industry-leading healthcare delivery assets,” Joyner told analysts last week on the company’s ...

Glenn Irwin will remain with the PBM Racing Team for the next two Bennetts British Superbike Championship seasons. Irwin will ...

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price ...

The Rubie Wallet showcases Purpose-Bound Money's (PBM) practical applications, simplifying the payment process for ...

The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).

The matter is relevant to the pharmacies as GoodRx markets a prescription drug discount card that customers can use at ...

Glenn Irwin has signed a new two-year deal with the PBM Ducati team for the 2025 and 2026 British Superbike Championship.

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

Three independent pharmacies have filed lawsuits accusing GoodRx, which markets a prescription drug discount card, of ...